Postoperative Management and Complications in Living-related Liver Transplantation

Tetsuya Shimizu, Takashi Tajiri, Koho Akimaru, Hiroshi Yoshida, Shigeki Yokomuro, Yasuhiro Mamada, Nobuhiko Taniai, Youichi Kawano, Yoshiaki Mizuguchi, Tsubasa Takahashi, Koichi Mizuta, Hideo KawarasakiJournal of Nippon Medical School 2003 · DOI

Abstract: Living-related liver transplantation (LRLT) has become a standard treatment for end-stage liver disease, achieving survival rates of up to 80%. However, the postoperative period is a complex "physiological tightrope," where clinicians must balance aggressive immunosuppression against the risks of systemic infection and vascular failure. This paper reviews the management protocols for acute rejection, vascular thrombosis, and infectious complications, highlighting the role of multidisciplinary care and interventional radiology in ensuring graft survival.

Introduction

While LRLT offers a life-saving alternative to cadaveric transplantation, it introduces unique postoperative challenges. Recipients are often hemodynamically unstable due to massive fluid shifts and are highly susceptible to complications that can lead to rapid graft loss. The primary clinical focus is on managing three critical threats: acute cellular rejection, vascular catastrophes (such as hepatic artery thrombosis), and systemic infections, which remain the leading cause of mortality.

Clinical Management and Monitoring Protocols

The protocols established at Nippon Medical School and Jichi Medical School emphasize a multifaceted approach to postoperative care:

  • Immunosuppression: A dual-drug regimen of Tacrolimus and Methylprednisolone is standard. Steroids are tapered using a "recycle method," with monoclonal antibodies (OKT3) reserved for steroid-resistant rejection.
  • Hemodynamic Stability: Managing "third space" fluid shifts is vital, as patients can gain significant water weight during prolonged surgeries, impacting organ perfusion.
  • Anticoagulation: To prevent thrombosis in small reconstructed vessels, low-molecular-weight heparin and Antithrombin III are used, requiring a delicate balance to avoid internal hemorrhage.
  • Vigilant Monitoring: Daily (often twice-daily) color Doppler ultrasound is essential for the early detection of vascular complications.
Doppler ultrasound monitoring of graft vasculature to detect early signs of thrombosis.

Key Insights: The Postoperative Timeline

Complications in LRLT typically follow a predictable chronological pattern. Intraabdominal bleeding is most common within the first 48 hours, while vascular thrombosis usually occurs within the first two weeks. Viral infections, such as Cytomegalovirus (CMV), typically emerge after the first month of immunosuppression.

A significant challenge in LRLT is the "small-for-size syndrome." If the donor graft volume is less than 40% of the recipient's standard liver volume, the risk of intractable ascites and cholestasis increases. Furthermore, outflow obstruction due to hepatic vein stenosis can occur, leading to liver dysfunction. In such cases, interventional radiology—specifically percutaneous balloon dilatation (venoplasty)—is a highly effective treatment.

Angiographic sequence demonstrating hepatic vein stenosis and successful percutaneous balloon dilatation.

Results and Outcomes

  • Survival Rates: Overall survival for LRLT has reached approximately 80%.
  • Rejection: Despite advanced drug regimens, acute rejection affects roughly 36% of patients.
  • Vascular Complications: Hepatic artery thrombosis (HAT) occurs in 1.3–12% of cases, often requiring emergency surgical intervention or retransplantation.
  • Infection: Infection remains the most significant cause of morbidity and mortality, accounting for 30–60% of postoperative deaths.

Conclusion

The success of living-related liver transplantation depends on prompt diagnosis and the integration of specialized expertise from hepatologists, surgeons, and radiologists. While surgical techniques and immunosuppressive agents have advanced, the core challenge remains the management of the immunocompromised state and the prevention of vascular failure. Future research must focus on optimizing immunosuppression to minimize infectious risks without compromising graft acceptance.

Summary updated

Abstract

Living-related liver transplantation is widely accepted as a treatment for patients with end-stage liver disease, with survival rates of up to 80%. Liver transplant recipients are at risk for the same postoperative complications as any patient undergoing a major intraabdominal operation, in addition to several complications specific to this procedure. Maintenance immunosuppression relies principally on administration of tacrolimus and methylprednisolone. Nevertheless, approximately 36% of liver transplant recipients suffer acute rejection in the early posttransplant period and require bolus steroid therapy as a rescue agent. Vascular complications, including hepatic arterial thrombosis and portal vein thrombosis, are additional major problems. When they occur in the immediate postoperative period, they can produce fulminant hepatic necrosis requiring retransplantation, so intensive anticoagulation therapy is needed as prophylaxis against these vascular complications. If thrombosis of the hepatic artery or portal vein is diagnosed early in the postoperative course, emergency thrombectomy with reanastomosis should be attempted. Outflow obstruction by hepatic vein stenosis sometimes causes liver dysfunction, pleural effusion, and hepatosplenomegaly. Percutaneous transhepatic or transjugular approached hepatic vein dilatation is very useful in case of hepatic vein stenosis. Recipients are generally immunocompromised secondary to immunosuppressive therapy and their poor clinical condition and are at high risk for postoperative infection. Infection is a major cause of morbidity and the most common cause of death in liver transplant recipients. Antibiotic, antifungal, and antiviral agents are used empirically, and serologic examinations and bacterial investigations of blood, sputum, stool, urine, and discharge from drains should be performed as well as antibiotic sensitivity tests when necessary. Other complications related to the operation are intraabdominal bleeding, bile leakage, biliary anastomotic stenosis, and intestinal perforation. The postoperative course of liver transplant recipients with these complications depends on making an accurate diagnosis promptly and initiating appropriate management. Postoperative complications of living-related liver transplantation are protean, so it is very important to communicate with professionals in each specialized field to ensure optimal treatment.
BibTeX
@article{shimizu2003postoperative,
  author = {Tetsuya Shimizu and Tetsuya Shimizu and Takashi Tajiri and Koho Akimaru and Hiroshi Yoshida and Shigeki Yokomuro and Yasuhiro Mamada and Nobuhiko Taniai and Youichi Kawano and Yoshiaki Mizuguchi and Tsubasa Takahashi and Koichi Mizuta and Hideo Kawarasaki},
  title = {{Postoperative Management and Complications in Living-related Liver Transplantation}},
  journal = {Journal of Nippon Medical School},
  year = {2003},
  doi = {10.1272/jnms.70.522},
}
Figure